Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04047316 · ClinicalTrials.gov registry record

Development and Validation of a New Digital Dermatoscope in the United States

A clinical trial of Skin Cancer, sponsored by Barco.

Completed
Registry status
60
Enrollment target
2
Study locations

NCT04047316: Completed study of Skin Cancer, sponsored by Barco.

NCT04047316 is a study of Skin Cancer that has completed, run by Barco. The registered enrollment target is 60 participants, below the 463-participant average among 40 other Skin Cancer trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04047316, a study of Skin Cancer, has completed, sponsored by Barco.

COMPLETED
Registry status
60 participants
Enrollment target
2
Study locations

Study Summary

A completely new type of digital dermatoscope has been developed in order to take a significant step forward in technology for skin cancer imaging. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Primary Outcome

The outcome will be measured by a questionnaire with performance-related questions for clinicians to answer about a set of images from the collected database. A Likert-based scale will be used for the answers: from highly agree to highly disagree.

Conditions Studied

Interventions

  • DEVICE Digital dermoscopy

Study Locations (2)

Maryland

  • Dermatologic Surgery Center of Washington LLC - Chevy Chase

Oregon

  • Silver Falls Dermatology - Salem

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-08-27
Est. Completion 2020-04-15
Barco

1 total trials

What the finished NCT04047316 record still lists

NCT04047316 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 463-participant average among 40 other Skin Cancer trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Digital dermoscopy is the first listed.

NCT04047316 reports a single indexed study location in Maryland, Oregon.

Frequently Asked Questions

What is clinical trial NCT04047316 about?

NCT04047316 is a clinical study titled "Development and Validation of a New Digital Dermatoscope in the United States". A completely new type of digital dermatoscope has been developed in order to take a significant step forward in technology for skin cancer imaging. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to f...

What is the current status of trial NCT04047316?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2019-08-27. Estimated completion is 2020-04-15.

What conditions does trial NCT04047316 study?

This clinical trial studies the following conditions: Skin Cancer.

What interventions are being tested in trial NCT04047316?

The interventions under investigation include: Digital dermoscopy (DEVICE).

Who is sponsoring clinical trial NCT04047316?

This trial is sponsored by Barco, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04047316 being conducted?

This trial has 2 study locations across Maryland, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04047316's enrollment target sits among peer trials

60 22nd of 40 higher than 19 of 40 other Skin Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Skin Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04047316, the US trial registry maintained by the National Library of Medicine. NCT04047316 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.